Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › RTS,S/AS01

RTS,S/AS01

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of RTS,S/AS01

2 trials tracked of RTS,S/AS01: 2 in phase 3 or 4 and 2 with published results. The most-cited published study has 235 citations.

2Trials tracked
2Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 3 2
  1. Phase 3 Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) Completed · 235 cited
  2. Phase 3 Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) Extension Study Completed · 70 cited

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
C-terminus IgG are more durable than NANP-repeats in RTS,S/AS01 malaria vaccine recipients
Drug Pipeline Phase III
C-terminus IgG are more durable than NANP-repeats in RTS,S/AS01 malaria vaccine recipients New data shows how malaria vaccine antibodies last longer
This observational ancillary study of a Phase 3 trial in 1292 children from six African countries found that C-terminus IgG levels declined …
A study of children in Africa shows that certain vaccine antibodies stay strong over time, helping to lower the risk of malaria.
Sep 20, 2026
Malaria vaccines RTS,S/AS01 and R21/Matrix-M reduce malaria risk in children
Pediatrics Meta-analysis
Malaria vaccines RTS,S/AS01 and R21/Matrix-M reduce malaria risk in children Malaria vaccines cut risk by 23% in infants, 39% in toddlers
This systematic review and meta-analysis of 8 studies found that RTS,S/AS01 and R21/Matrix-M vaccines reduce malaria risk in children. In th…
Two malaria vaccines, RTS,S and R21, reduce malaria risk by 23% in young infants and 39% in older children, a review finds.
Jun 7, 2026